Page last updated: 2024-08-24

ibandronic acid and Renal Insufficiency

ibandronic acid has been researched along with Renal Insufficiency in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergner, R; Gretz, N; Kränzlin, B; Pohlmeyer-Esch, G; Siegrist, B1
Antràs, L; Diel, IJ; Duh, MS; Green, J; Köppler, H; Neary, M; Smith, M; Weide, R; Wintfeld, N1
Grieve, RJ; Hamilton, E; Hickish, T; Houston, S; Percival, F1
Abadie-Lacourtoisie, S; Dür, C; Frimat, L; Lefeuvre, C; Letessier, S; Lortholary, A; Mefti-Lacheraf, F; Morvan, P; Pivot, X; Pujade-Lauraine, E1
Bauss, F; Brkovic, D; Jakse, G; Linke, J1
Jackson, GH1
Bergner, R; Henrich, DM; Hoffmann, M; Honecker, A; Mikus, G; Nagel, D; Nauth, B; Uppenkamp, M1
Civitelli, R; Emkey, R; Strampel, W1

Reviews

2 review(s) available for ibandronic acid and Renal Insufficiency

ArticleYear
Renal safety of ibandronate.
    The oncologist, 2005, Volume: 10 Suppl 1

    Topics: Bone Density Conservation Agents; Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Dose-Response Relationship, Drug; Humans; Ibandronic Acid; Kidney; Multiple Myeloma; Renal Insufficiency; Urologic Neoplasms

2005
Safety considerations with bisphosphonates for the treatment of osteoporosis.
    Drug safety, 2007, Volume: 30, Issue:9

    Topics: Acute-Phase Reaction; Administration, Oral; Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Gastrointestinal Diseases; Humans; Ibandronic Acid; Injections, Intravenous; Jaw Diseases; Osteonecrosis; Osteoporosis, Postmenopausal; Renal Insufficiency; Risedronic Acid

2007

Trials

2 trial(s) available for ibandronic acid and Renal Insufficiency

ArticleYear
Renal safety of ibandronate 6 mg infused over 15 min versus 60 min in breast cancer patients with bone metastases: a randomized open-label equivalence trial.
    Breast (Edinburgh, Scotland), 2011, Volume: 20, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Middle Aged; Renal Insufficiency; Treatment Outcome

2011
Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal function.
    Journal of clinical pharmacology, 2007, Volume: 47, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency

2007

Other Studies

4 other study(ies) available for ibandronic acid and Renal Insufficiency

ArticleYear
Nephrotoxicity of ibandronate and zoledronate in Wistar rats with normal renal function and after unilateral nephrectomy.
    Pharmacological research, 2015, Volume: 99

    Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Kidney; Nephrectomy; Rats; Rats, Wistar; Renal Insufficiency; Zoledronic Acid

2015
Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Cancer Care Facilities; Creatinine; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Male; Middle Aged; Multivariate Analysis; Neoplasms; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Zoledronic Acid

2009
Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study.
    Journal of medical economics, 2010, Volume: 13, Issue:1

    Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Health Care Costs; Health Resources; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Kidney; Kidney Function Tests; Middle Aged; Renal Insufficiency; State Medicine; Zoledronic Acid

2010
Changes in bone structure after augmentation cystoplasty in chronic uraemic rats.
    BJU international, 2005, Volume: 95, Issue:7

    Topics: Animals; Bone Density; Bone Resorption; Chronic Disease; Diphosphonates; Female; Ibandronic Acid; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Uremia; Urinary Diversion

2005